Cargando…
Binding modes of potential anti-prion phytochemicals to PrP(C) structures in silico
BACKGROUND: Prion diseases involve the conversion of a normal, cell-surface glycoprotein (PrP(C)) into a misfolded pathogenic form (PrP(Sc)). One possible strategy to inhibit PrP(Sc) formation is to stabilize the native conformation of PrP(C) and interfere with the conversion of PrP(C) to PrP(Sc). M...
Autores principales: | Neupane, Sandesh, Khadka, Jenisha, Rayamajhi, Sandesh, Pandey, Arti S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368899/ https://www.ncbi.nlm.nih.gov/pubmed/37453159 http://dx.doi.org/10.1016/j.jaim.2023.100750 |
Ejemplares similares
-
The Structure of PrP(Sc) Prions
por: Wille, Holger, et al.
Publicado: (2018) -
Anti-Prion Drug mPPIg5 Inhibits PrP(C) Conversion to PrP(Sc)
por: McCarthy, James M., et al.
Publicado: (2013) -
Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
por: Sakudo, Akikazu, et al.
Publicado: (2015) -
Exploration of the Main Sites for the Transformation of Normal Prion Protein (PrP(C)) into Pathogenic Prion Protein (PrP(sc))
por: Liu, Xi-Lin, et al.
Publicado: (2017) -
A Camelid Anti-PrP Antibody Abrogates PrP(Sc) Replication in Prion-Permissive Neuroblastoma Cell Lines
por: Jones, Daryl Rhys, et al.
Publicado: (2010)